Moreover, the variation of detection method, with one study using clinical cDNA microarrays, another RT-PCR, and the remaining IHC, can result in errors, since the RNA levels of CSN5 in tumor cells might differ from its protein level. This evidence concerns the gene COPS5 and neoplasm.